Giuseppe Bardi

Scopus Author ID ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 12

Top Venues

Nanomaterials (Basel, Switzerland)

Vaccines

Nanomedicine (London, England)

Materials (Basel, Switzerland)

Istituto Italiano di Tecnologia

Universität Bern (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istituto Italiano di Tecnologia Feb 01 2011

Italy

Researcher

Istituto di Neuroscienze Consiglio Nazionale delle Ricerche Oct 01 2006 - Dec 31 2010

Italy

Research Associate

Drexel University College of Medicine Jan 01 2005 - May 31 2006

United States

Research Associate :: Pharmacology and Physiology

Temple University School of Medicine Jan 01 2004 - Dec 31 2004

United States

Postodoctoral Fellowship :: FELS Institute for Cancer Research and Molecular Biology

Babraham Institute Nov 01 2001 - Feb 28 2003

United Kingdom

Postdoctoral Fellowship :: Molecular Immunology Programme, Lymphocyte Signalling and Development Laboratory

Education History

Universität Bern May 01 1998 - Mar 29 2001

Switzerland

PHD :: Theodor Kocher Institute

Publications

Giuseppe Bardi, Luca Boselli, Pier Paolo Pompa
Anti-inflammatory potential of platinum nanozymes: mechanisms and perspectives. Nanoscale (2023)
Salvatore Calogero Gaglio, Massimiliano Perduca, Donato Zipeto, Giuseppe Bardi
Efficiency of Chitosan Nanocarriers in Vaccinology for Mucosal Immunization. Vaccines 11 (8) (2023)
Anissa Pisani, Roberto Donno, Giulio Valenti, Pier Paolo Pompa, Nicola Tirelli, Giuseppe Bardi
Chemokine-Decorated Nanoparticles Target Specific Subpopulations of Primary Blood Mononuclear Leukocytes. Nanomaterials (Basel, Switzerland) 12 (20) (2022)
Giuseppe Bardi, Monica Teodora Neagu
Moving Forward in Nano-Immune Interactions. Nanomaterials (Basel, Switzerland) 12 (12) (2022)
Carolina Constantin, Anissa Pisani, Giuseppe Bardi, Monica Teodora Neagu
Nano-carriers of COVID-19 vaccines: the main pillars of efficacy. Nanomedicine (London, England) 16 (26) (2021)
Giuseppe Bardi
Immune Responses to Nanomaterials for Biomedical Applications. Nanomaterials (Basel, Switzerland) 11 (5) (2021)
Anissa Pisani, Roberto Donno, Arianna Gennari, Giulia Cibecchini, Federico Catalano, Roberto Marotta, Pier Paolo Pompa, Nicola Tirelli, Giuseppe Bardi
CXCL12-PLGA/Pluronic Nanoparticle Internalization Abrogates CXCR4-Mediated Cell Migration. Nanomaterials (Basel, Switzerland) 10 (11) (2020)
Giuseppe Bardi
Nanometric Virus-Like Particles: Key Tools for Vaccine and Adjuvant Technology. Vaccines 8 (3) (2020)
Roberta Cagliani, Francesca Gatto, Giuseppe Bardi
Protein Adsorption: A Feasible Method for Nanoparticle Functionalization? Materials (Basel, Switzerland) 12 (12) (2019)
Francesca Gatto, Giuseppe Bardi
Metallic Nanoparticles: General Research Approaches to Immunological Characterization. Nanomaterials (Basel, Switzerland) 8 (10) (2018)
Francesca Gatto, Mauro Moglianetti, Pier Paolo Pompa, Giuseppe Bardi
Platinum Nanoparticles Decrease Reactive Oxygen Species and Modulate Gene Expression without Alteration of Immune Responses in THP-1 Monocytes. Nanomaterials (Basel, Switzerland) 8 (6) (2018)
Francesca Gatto, Roberta Cagliani, Tiziano Catelani, Daniela Guarnieri, Mauro Moglianetti, Pier Paolo Pompa, Giuseppe Bardi
PMA-Induced THP-1 Macrophage Differentiation is Not Impaired by Citrate-Coated Platinum Nanoparticles. Nanomaterials (Basel, Switzerland) 7 (10) (2017)

Giuseppe Bardi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Giuseppe Bardi